Torrent Pharmaceuticals Ltd Analyst Rating
based on 28 analysts
62.07%
Buy
24.14%
Hold
13.79%
Sell
Based on 28 analysts offering long term price targets for Torrent Pharmaceuticals Ltd. An average target of ₹3637.5
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Share analysis
Torrent Pharmaceuticals Ltd price forecast by 28 analysts
Upside of14.57%
High
₹4232
Target
₹3637.50
Low
₹2930
Torrent Pharmaceuticals Ltd target price ₹3637.5, a slight upside of 14.57% compared to current price of ₹3174.85. According to 28 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Torrent Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:40.88%
Forecast
Actual
Including amortisation and stock based compensations
Torrent Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:91.56%
Forecast
Actual
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹3,152.2Day's Price Range₹3,201.2552 Week's Low
52 Week's High
₹2,407.2552-Week Price Range₹3,590.7
| Returns % | |
| 1 Month Return | -6.12 % |
| 3 Month Return | -7.96 % |
| 1 Year Return | + 28.93 % |
| Market Stats | |
| Previous Close | ₹3,178.60 |
| Open | ₹3,163.20 |
| Volume | 2.23L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,07,573.44Cr |
Torrent Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 59.62 |
| PEG Ratio | 4.39 |
| Market Cap | ₹1,07,573.44 Cr |
| P/B Ratio | 12.89 |
| EPS | 48.94 |
| Dividend Yield | 1.08 |
| Sector | Pharmaceuticals |
| ROE | 20.43 |
Torrent Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹1,07,573.44 Cr | 42.63% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
| HOLD | ₹1,57,052.54 Cr | 42.54% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
| HOLD | ₹47,201.59 Cr | 6.96% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
| HOLD | ₹27,609.92 Cr | -1.54% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
| BUY | ₹1,16,579.09 Cr | 40.08% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
Torrent Pharmaceuticals Ltd Mutual Fund Holdings
About Torrent Pharmaceuticals Ltd
The company is focused on producing high-quality, affordable medicines for the treatment of a wide range of diseases. Its top products include cardiovascular drugs, antibiotics, anti-diabetic drugs, anti-inflammatory drugs, and anti-infective drugs. Popular brands include Cadila, Torleva, Torlip, and Torleva XR.
Share Price: ₹3174.85 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹1,07,573.44Cr as of today
Revenue: ₹2,831.00Cr as on September 2024 (Q3 24)
Net Profit: ₹453.00Cr as on September 2024 (Q3 24)
Listing date: 03 Nov, 1994
Chairperson Name: Sudhir Mehta
| Organisation | Torrent Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Torrent Pharmaceuticals Ltd
Torrent Pharma Plans Interim Dividend Meeting - 13 Jan, 2025
Torrent Pharmaceuticals Ltd. will hold a board meeting on January 24 to discuss the potential payment of an interim dividend, with a record date set for February 1.Torrent Pharmaceuticals Receives 'Hold' Rating Amid Growth - 06 Jan, 2025
Torrent Pharmaceuticals has received a 'Hold' rating following strong financial performance, including a 29.31% increase in profit after tax and a 42.84% return over the past year. The company shows robust financial health with consistent growth and positive cash flow.Torrent Pharma Shows Positive Momentum Above Key Levels - 23 Dec, 2024
Torrent Pharmaceuticals is maintaining an uptrend, recently breaking above the Rs 3,400 resistance level. Analysts suggest accumulating shares in the Rs 3,400-3,435 range, targeting Rs 3,700-3,750, with a stop loss below Rs 3,200.Torrent Pharmaceuticals Shows Strong Growth Potential - 19 Dec, 2024
Torrent Pharmaceuticals Ltd has seen a significant rise, up 61.34% over the past year. Analysts suggest a buy with a target price of ₹1,010-1,030, anticipating further gains of 10-12%. The stock is currently up 2.43% today.
Insights on Torrent Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 14.22% to 14.46% in Sep 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 71.25% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 15.9%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 0.6%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 7.26% to 7.21% in Sep 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 457.0 Cr → 453.0 Cr (in ₹), with an average decrease of 0.9% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.88K Cr → 2.87K Cr (in ₹), with an average decrease of 0.4% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, TORNTPHARM stock has moved down by -3.8%
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 4.35% to 3.69% in Sep 2024 quarter
Torrent Pharmaceuticals Ltd Financials
Index Inclusions
Torrent Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.25% | 0.00 | |
| Foreign Institutions | 14.46% | 1.68 | |
| Mutual Funds | 3.69% | ||
| Retail Investors | 7.21% | ||
| Others | 3.4% | 16.12 |
Torrent Pharmaceuticals Ltd Key Indicators
Torrent Pharmaceuticals Ltd Valuation
Torrent Pharmaceuticals Ltd in the last 5 years
Lowest (31.60x)
April 2, 2018
Industry (54.95x)
January 17, 2025
Today (59.62x)
January 17, 2025
Highest (73.85x)
April 3, 2019
Torrent Pharmaceuticals Ltd Earnings and Dividends
Torrent Pharmaceuticals Ltd Earnings Results
Torrent Pharmaceuticals Ltd’s net profit jumped 17.36% since last year same period to ₹453Cr in the Q2 2024-2025. On a quarterly growth basis, Torrent Pharmaceuticals Ltd has generated -0.88% fall in its net profits since last 3-months.
Read More about Earnings ResultsTorrent Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Torrent Pharmaceuticals Ltd has declared dividend of ₹6 - translating a dividend yield of 1.13%.
Read More about Dividends
Torrent Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Torrent Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd share price today stands at ₹3174.85, Open. ₹3163.2 ; Previous Close. ₹3178.6 ; High. ₹3201.25 ; Low. ₹3152.2 ; 52 Week High. ₹3590.7 ; 52 Week Low: ₹2407.25.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Torrent Pharmaceuticals Ltd shares.
Torrent Pharmaceuticals Ltd is listed on NSE
Torrent Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Torrent Pharmaceuticals Ltd is ₹3201.25.
- Today’s lowest price of Torrent Pharmaceuticals Ltd is ₹3152.2.
PE Ratio of Torrent Pharmaceuticals Ltd is 59.62
PE ratio = Torrent Pharmaceuticals Ltd Market price per share / Torrent Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Torrent Pharmaceuticals Ltd(TORNTPHARM) is 2.23L.
Today’s market capitalisation of Torrent Pharmaceuticals Ltd(TORNTPHARM) is ₹107573.44Cr.
| Torrent Pharmaceuticals Ltd(TORNTPHARM | Price |
|---|---|
52 Week High | ₹3590.7 |
52 Week Low | ₹2407.25 |
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹3174.85. It is down -11.58% from its 52 Week High price of ₹3590.7
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹3174.85. It is up 31.89% from its 52 Week Low price of ₹2407.25
| Torrent Pharmaceuticals Ltd(TORNTPHARM | Returns |
|---|---|
1 Day Returns | -3.75% |
1 Month Returns | -6.12% |
3 Month Returns | -7.96% |
1 Year Returns | 28.93% |